GRIN2A and Alzheimer disease: Indeed, it was recently shown that enhancing GluN2A activity in both excitatory and inhibitory interneurons with the use of the positive allosteric modulator (PAM) GNE-0723 reduced epileptiform activity in mouse models of Alzheimer’s disease (AD) and Dravet syndrome [57].